PureCycle proposes $250M convertible notes and $145M stock sale
PCT•PureCycle commenced underwritten offerings of $250 million convertible senior notes due 2032 and $145 million common stock, each with 30-day over-allotment options of $37.5 million and $18.75 million, respectively. Net proceeds will repurchase its 7.25% green convertible notes due 2030 and fund working capital and other corporate purposes.
1. Details of Proposed Offerings
PureCycle has commenced underwritten public offerings of $250 million in convertible senior notes due 2032 and $145 million of common stock, with underwriters granted 30-day over-allotment options for up to $37.5 million of additional notes and $18.75 million of additional shares. Interest rate, conversion rate and other note terms will be determined at pricing.
2. Use of Proceeds
The company intends to apply net proceeds to repurchase a portion of its outstanding 7.25% green convertible notes due 2030 in privately negotiated transactions and may repurchase additional Green Convertible Notes over time. Remaining proceeds will support working capital and general corporate purposes.
3. Impact and Strategic Context
This financing will enable PureCycle to reduce its high-coupon debt burden and enhance liquidity, potentially lowering future interest expenses. However, the equity component and potential note conversions could lead to share count expansion and dilution for existing shareholders.
4. Underwriting and Regulatory Filing
Morgan Stanley is acting as sole bookrunner for both offerings, which are being conducted under an effective Form S-3 shelf registration statement. The offerings are subject to market conditions and finalizing prospectus supplements and accompanying prospectuses.
